GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yumanity Therapeutics Inc (FRA:8IY) » Definitions » Total Assets

Yumanity Therapeutics (FRA:8IY) Total Assets : €9.68 Mil (As of Sep. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Yumanity Therapeutics Total Assets?

Yumanity Therapeutics's Total Assets for the quarter that ended in Sep. 2022 was €9.68 Mil.

Total Assets is connected with ROA %. Yumanity Therapeutics's annualized ROA % for the quarter that ended in Sep. 2022 was -111.79%. Total Assets is also linked to Revenue through Asset Turnover. Yumanity Therapeutics's Asset Turnover for the quarter that ended in Sep. 2022 was 0.12.


Yumanity Therapeutics Total Assets Historical Data

The historical data trend for Yumanity Therapeutics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yumanity Therapeutics Total Assets Chart

Yumanity Therapeutics Annual Data
Trend Dec19 Dec20 Dec21
Total Assets
15.85 94.39 55.70

Yumanity Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 59.35 55.70 28.66 14.63 9.68

Yumanity Therapeutics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Yumanity Therapeutics's Total Assets for the fiscal year that ended in Dec. 2021 is calculated as

Total Assets=Total Equity (A: Dec. 2021 )+Total Liabilities (A: Dec. 2021 )
=20.795+34.9
=55.70

Yumanity Therapeutics's Total Assets for the quarter that ended in Sep. 2022 is calculated as

Total Assets=Total Equity (Q: Sep. 2022 )+Total Liabilities (Q: Sep. 2022 )
=5.531+4.144
=9.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yumanity Therapeutics  (FRA:8IY) Total Assets Explanation

Total Assets is connected with ROA %.

Yumanity Therapeutics's annualized ROA % for the quarter that ended in Sep. 2022 is

ROA %=Net Income (Q: Sep. 2022 )/( (Total Assets (Q: Jun. 2022 )+Total Assets (Q: Sep. 2022 ))/ count )
=-13.588/( (14.634+9.675)/ 2 )
=-13.588/12.1545
=-111.79 %

Note: The Net Income data used here is four times the quarterly (Sep. 2022) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Yumanity Therapeutics's Asset Turnover for the quarter that ended in Sep. 2022 is

Asset Turnover
=Revenue (Q: Sep. 2022 )/( (Total Assets (Q: Jun. 2022 )+Total Assets (Q: Sep. 2022 ))/ count )
=1.416/( (14.634+9.675)/ 2 )
=1.416/12.1545
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Yumanity Therapeutics Total Assets Related Terms

Thank you for viewing the detailed overview of Yumanity Therapeutics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Yumanity Therapeutics (FRA:8IY) Business Description

Traded in Other Exchanges
N/A
Address
40 Guest Street, Suite 4410, Boston, MA, USA, 02135
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.

Yumanity Therapeutics (FRA:8IY) Headlines

No Headlines